170 related articles for article (PubMed ID: 23782223)
1. Secondary primary cancer in patients with head and neck carcinoma: the differences among hypopharyngeal, laryngeal, and other sites of head and neck cancer.
Liu WS; Chang YJ; Lin CL; Liang JA; Sung FC; Hwang IM; Kao CH
Eur J Cancer Care (Engl); 2014 Jan; 23(1):36-42. PubMed ID: 23782223
[TBL] [Abstract][Full Text] [Related]
2. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
Jégu J; Binder-Foucard F; Borel C; Velten M
Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
[TBL] [Abstract][Full Text] [Related]
3. Acid reflux and head and neck cancer risk: A nationwide registry over 13 years.
Kuo CL; Chen YT; Shiao AS; Lien CF; Wang SJ
Auris Nasus Larynx; 2015 Oct; 42(5):401-5. PubMed ID: 25998850
[TBL] [Abstract][Full Text] [Related]
4. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
[TBL] [Abstract][Full Text] [Related]
5. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer arising after endoscopic mucosal resection for squamous cell carcinoma of the esophagus.
Shimizu Y; Tsukagoshi H; Fujita M; Hosokawa M; Watanabe A; Kawabori S; Kato M; Sugiyama T; Asaka M
Endoscopy; 2003 Apr; 35(4):322-6. PubMed ID: 12664389
[TBL] [Abstract][Full Text] [Related]
7. Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis.
Lin YS; Yeh CC; Huang SF; Chou YS; Kuo LT; Sung FC; Muo CH; Su CT; Su FH
PLoS One; 2018; 13(8):e0199014. PubMed ID: 30133455
[TBL] [Abstract][Full Text] [Related]
8. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
Rusthoven K; Chen C; Raben D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
[TBL] [Abstract][Full Text] [Related]
9. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control.
de Souza DL; Pérez MM; Curado MP
Cancer Epidemiol; 2011 Dec; 35(6):510-4. PubMed ID: 21470934
[TBL] [Abstract][Full Text] [Related]
10. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan.
Tseng KS; Lin C; Lin YS; Weng SF
JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):746-53. PubMed ID: 25058016
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma.
Dikshit RP; Boffetta P; Bouchardy C; Merletti F; Crosignani P; Cuchi T; Ardanaz E; Brennan P
Cancer; 2005 Jun; 103(11):2326-33. PubMed ID: 15852357
[TBL] [Abstract][Full Text] [Related]
12. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
13. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
14. Cortactin as a potential predictor of second esophageal neoplasia in hypopharyngeal carcinoma.
Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA
Auris Nasus Larynx; 2019 Apr; 46(2):260-266. PubMed ID: 30107961
[TBL] [Abstract][Full Text] [Related]
15. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
16. Second cancer incidence and risk factors in patients with salivary gland cancers.
Kwon M; Lee JI; Roh JL; Cho KJ; Choe J; Choi SH; Nam SY; Kim SY
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):118-23. PubMed ID: 24370632
[TBL] [Abstract][Full Text] [Related]
17. Effect of routine esophageal screening in patients with head and neck cancer.
Su YY; Chen WC; Chuang HC; Guo CS; Lin YT; Luo SD; Fang FM; Chien CY
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):350-4. PubMed ID: 23519755
[TBL] [Abstract][Full Text] [Related]
18. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults.
Braakhuis BJ; Visser O; Leemans CR
Oral Oncol; 2009 Sep; 45(9):e85-9. PubMed ID: 19457708
[TBL] [Abstract][Full Text] [Related]
19. Previous head and neck cancers portend poor prognoses in lung cancer patients.
Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
[TBL] [Abstract][Full Text] [Related]
20. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
